Heart rate is a marker of amiodarone mortality reduction in severe heart failure

Journal of the American College of Cardiology

Volumn 29, Issue 6, 1997, Pages 1199-1205

  Nul, Daniel R ^a   Doval, Hernán C ^a   Grancelli, Hugo O ^a   Varini, Sergio D ^a   Soifer, Saul ^a   Perrone, Sergio V ^a   Prieto, Noemí ^a   Scapin, Omar ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; MARKER;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0030958383     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00066-1     Document Type: Article

References (31)

1. Francis G. Development of arrhythmia in the patient with congestive heart failure pathophysiology, prevalence and prognosis . Am J Cardiol. 57:(Suppl):1986;3B-7B.
2. Gradman A, Deedwania P, Cody R, et al. Prediction of total morbidity and sudden death in mild to moderate heart failure. J Am Coll Cardiol. 14:1989;564-570.
3. Podrid P, Fogel R, Fuchs T. Ventricular arrhythmia in congestive heart failure. Am J Cardiol. 69:1992;82G-96G.
4. Bigger T. Why patients with congestive heart failure die arrhythmias and sudden cardiac death . Circulation. 75:(Suppl IV):1987;IV-28-IV-35.
5. Stevenson WG. Mechanisms and management of arrhythmias in heart failure. Curr Opin Cardiol. 10:1995;274-281.
6. Dargie H, Cleland J, Leckie B, Inglis C, East B, Ford I. Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients with heart failure. Br Heart J. 57:1987;436-445.
7. Chatterjee K. Amiodarone in chronic heart failure. J Am Coll Cardiol. 14:1989;75-76.
8. Podrid PJ. Amiodarone reevaluation of an old drug . Ann Intern Med. 122:1995;689-700.
9. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone associated proarrhythmic effects a review with special reference to torsade pointes tachycardia . Ann Intern Med. 121:1994;529-535.
10. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomized trial of low-dose amiodarone in severe heart failure. Lancet. 344:1994;493-498.
11. Venkatesh N, Padbury JF, Singh BN. Effects of amiodarone and desethylamiodarone on rabbit myocardial β-adrenoreceptors and serum thyroid hormones - absence of relationship to serum and myocardial drug concentrations. J Cardiovasc Pharmacol. 8:1986;989-997.
12. Sager PT, Uppal P, Follmer C, Antimisisiaris M, Pruitt C, Singh BN. Frequency-dependent electrophysiologic effects of amiodarone in humans. Circulation. 88:1993;1063-1071.
13. Cohn J, Johnson G, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation. 87:(Suppl VI):1993;VI-5-VI16.
14. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol. 57:1986;43F-49F.
15. Singh B, Ahmed R. Class III antiarrhythmic drugs. Current Opin Cardiol. 9:1994;12-22.
16. Singh BN, Courtney K. On the classification of anti-arrhythmic mechanisms: experimental and clinical correlations. Zipes DP, Jalife J. Cardiac Electrophysiology: From Cell to the Bedside. 1990;882-897 W.B. Saunders, Philadelphia.
17. Colatsky TJ, Follmer CH, Starmer CF. Channel specificity in antiarrhythmic drug action mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias . Circulation. 82:1990;2235-2242.
18. Antimisiaris M, Sarma JSM, Schoenbaum MP, Sharma PP, Venkataraman K, Singh BN. Effects of amiodarone on the circadian rhythm and power spectral changes of heart rate and QT interval significance for the control of sudden death . Am Heart J. 128:1994;884-891.
19. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 333:1995;77-82.
20. Hamer AWF, Arkles LB, Johns JA. Beneficial effects of low dose amiodarone in patients with congestive heart failure a placebo-controlled trial . J Am Coll Cardiol. 14:1989;1768-1774.
21. Mahmarian JJ, Smart FW, Moyé LA, et al. Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity. Am J Cardiol. 74:1994;681-686.
22. Massie BM, Fisher SG, Deedwania PC, Singh BN, Fletcher RD, Singh SN. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. Circulation. 93:1996;2128-2134.
23. Freedman M, Somberg JC. Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol. 31:1991;1061-1069.
24. Eichorn EJ. The paradox of beta adrenergic blockade for the management of congestive heart failure. Am J Med. 92:1992;527-538.
25. Anderson B, Lomsky M, Waagstein F. The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. Eur Heart J. 14:1993;1375-1385.
26. A randomized trial of β-blockade in heart failure the Cardiac Insufficiency Bisoprolol Study (CIBIS) . Circulation. 90:1994;1765-1780.
27. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
28. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 325:1991;1468-1475.
29. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 325:1991;303-310.
30. Waagstein F, Bristow M, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 342:1993;1441-1446.
31. Mullieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR. Altered myocardial force-frequency relation in human heart failure. Circulation. 85:1992;1743-1750.